Academia.eduAcademia.edu

Outline

Tuberculosis in prisons in countries with high prevalence

2000, BMJ: British Medical …

Abstract
sparkles

AI

This article addresses the critical issue of tuberculosis (TB) in prisons located in countries with high prevalence rates. It highlights the unique challenges associated with TB control in these closed institutions, where prisoner mobility and administrative reporting issues complicate public health efforts. Emphasizing the importance of integrating effective TB control programs within prison systems, the article provides an overview of the current epidemiology of TB among prisoners and discusses the necessity of collaborative action between health authorities and prison administrations to tackle this public health crisis.

References (15)

  1. Drobniewski F. Tuberculosis in prisons-forgotten plague. Lancet 1995;345:948-9.
  2. Wares DF, Clowes CI. Tuberculosis in Russia. Lancet 1997;350:957.
  3. Coninx R, Eshaya-Chauvin B, Reyes H. Tuberculosis in prisons. Lancet 1995;346:1238-9.
  4. Aerts A. Prevalence of infectious tuberculosis in the prison population of Georgia. Int J Tuberculosis Lung Dis 1998;2(suppl 2):S193.
  5. Koffi N, Ngom AK, Aka-Danguy E, Seka A, Akoto A, Fadiga Dl. Smear posi- tive pulmonary tuberculosis in a prison setting: experience in the penal camp of Bouake, Ivory Coast. Int J Tuberculosis Lung Dis 1997;3:250-3.
  6. Auregan G, Rakotomanana F, Ratsitorahina M, Rakotoniaina N, Rabemananjara O, Raharimanan R, et al. La tuberculose en milieu carcéral a Atananarivo de 1990 à 1993. Arch Inst Pasteur Madagascar 1995;62(1):18-23.
  7. Nyangulu DS, Harries AD, Kang'ombe C, Yadidi AE, Chikani K, Cullinan T, et al. Tuberculosis in a prison population in Malawi. Lancet 1997;350:1284-7.
  8. World Health Organisation. Global tuberculosis programme. Global tubercu- losis control. Geneva: World Health Organisation, 1997. (WHO/TB/ 97.225:66.)
  9. 9 Goldfarb A, Kimerling ME. Public Health Research Institute/Soros Foundation interim report on the Russian TB program. New York: Public Health Research Institute, 1999.
  10. MacIntyre CR, Kendig N, Kummer L, Birago S, Graham NMH. Impact of tuberculosis control measures and crowding on the incidence of tubercu- lous infection in Maryland prisons. Clin Infect Dis 1997;24:1060-7.
  11. Bellin EY, Fletcher DD, Safyer SM. Association of tuberculosis infection with increased time in or admission to the New York City jail system. JAMA 1993;269:2228-31.
  12. Reyes H, Coninx R. Pitfalls of tuberculosis programmes in prisons. BMJ 1997;315:1447-50.
  13. Pablos-Méndez A, Raviglione MC, Laslo A, Binkin N, Rieder H, Bustreo F, et al. Global surveillance for antituberculosis-drug resistance, 1994-1997. N Engl J Med 1998;338:1641-9.
  14. Maher D, Grzemska M, Coninx R, Reyes H. Guidelines for the control of tuberculosis in prisons. Geneva: World Health Organisation, 1998. (WHO/ TB/98.250.)
  15. MaherD, Chaulet P, Spinaci S, Harries A. Treatment of tuberculosis: guidelines for national programmes. 2nd ed. Geneva, World Health Organis- ation, 1997. (WHO/TB/97.270.) (Accepted 15 October 1999)